ARTICLE | Clinical News
Alnylam preclinical data
January 21, 2013 8:00 AM UTC
In a mouse model of beta-thalassemia, ALN-TMP reduced the severity of anemia as demonstrated by an approximate 1 g/dL increase in total hemoglobin and a 50% reduction in circulating erythropoietin lev...